256940 Stock Chart & Stats
₩5330.00
-₩490.00(-8.42%)
―
--
Day’s Range― - ―
52-Week Range₩5,110.00 - ₩14,250.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)43.74K
Market Cap
₩116.85B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,078,148
10 Day Avg. Volume43,137
30 Day Avg. Volume43,736
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
256940 FAQ
What was Keeps Biopharma Inc.’s price range in the past 12 months?
Keeps Biopharma Inc. lowest stock price was ₩5110.00 and its highest was ₩14250.00 in the past 12 months.
What is Keeps Biopharma Inc.’s market cap?
Keeps Biopharma Inc.’s market cap is ₩116.85B.
When is Keeps Biopharma Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Keeps Biopharma Inc.’s earnings last quarter?
Keeps Biopharma Inc. released its earnings results on May 15, 2026. The company reported ₩282.264 earnings per share for the quarter, beating the consensus estimate of N/A by ₩282.264.
Is Keeps Biopharma Inc. overvalued?
According to Wall Street analysts Keeps Biopharma Inc.’s price is currently Undervalued.
Does Keeps Biopharma Inc. pay dividends?
Keeps Biopharma Inc. does not currently pay dividends.
What is Keeps Biopharma Inc.’s EPS estimate?
Keeps Biopharma Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Keeps Biopharma Inc. have?
Keeps Biopharma Inc. has 20,078,148 shares outstanding.
What happened to Keeps Biopharma Inc.’s price movement after its last earnings report?
Keeps Biopharma Inc. reported an EPS of ₩282.264 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.91%.
Which hedge fund is a major shareholder of Keeps Biopharma Inc.?
Currently, no hedge funds are holding shares in KR:256940
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ISU Abxis Co., Ltd.
―
Genexine, Inc.
―
Kyongbo Pharmaceutical Co., Ltd.
―
Aptabio Therapeutics, Inc.
―
ViGenCell, Inc.
―